Reductions in Use of Colchicine after FDA Enforcement of Market Exclusivity in a Commercially Insured Population.
about
Good Intentions, Unintended Consequences, and Unrealized Benefits.The rising prevalence and incidence of gout in British Columbia, Canada: Population-based trends from 2000 to 2012.Upstream biomanufacturing of pharmaceutical colchicine.Colchicine intoxication in familial Mediterranean fever patients using clarithromycin for the treatment of Helicobacter pylori: a series of six patients.
P2860
Reductions in Use of Colchicine after FDA Enforcement of Market Exclusivity in a Commercially Insured Population.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Reductions in Use of Colchicin ...... mmercially Insured Population.
@ast
Reductions in Use of Colchicin ...... mmercially Insured Population.
@en
type
label
Reductions in Use of Colchicin ...... mmercially Insured Population.
@ast
Reductions in Use of Colchicin ...... mmercially Insured Population.
@en
prefLabel
Reductions in Use of Colchicin ...... mmercially Insured Population.
@ast
Reductions in Use of Colchicin ...... mmercially Insured Population.
@en
P2093
P2860
P1476
Reductions in Use of Colchicin ...... ommercially Insured Population
@en
P2093
Daniel H Solomon
Jessica M Franklin
John D Seeger
P2860
P2888
P304
P356
10.1007/S11606-015-3285-7
P577
2015-04-09T00:00:00Z